Invus

Funding rounds backed by Invus.

Export CSV
Funding disclosed in full
$1B
Median round
$250M
Rounds in calculation
5
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
LifeMine Therapeutics

Develops fungal genome-derived therapeutics for organ transplant rejection

$263MSeries D+Series EBiotechUnited States
9 participantsARCH Venture PartnersBezos ExpeditionsGates FrontierGSKGV (Google Ventures)InvusLoLa Capital PartnersMilky Way InvestmentsRA Capital Management
City Therapeutics

Develops next-generation RNAi therapeutics and engineering platform for multiple disease areas

$99.5MSeries BBiotechUnited States
11 participantsAN VenturesARCH Venture PartnersCasdin CapitalFidelity Management & Research CompanyInvusNYBC VenturesRegeneron VenturesRock Springs CapitalSlate Path CapitalSofinnova InvestmentsViking Global Investors
Contraline

Develops hormonal and non-hormonal male contraceptives for men and couples globally

$92.5MSeries BBiotechUnited States
5 participantsBVF Partners L.P.GV (Google Ventures)InvusLumira VenturesRA Capital Management
Flexiv

Develops and manufactures adaptive robots for complex tasks

UndisclosedStrategicRoboticsUnited States
2 participantsAtma CapitalInvus
Mirador Therapeutics

Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases

$250MSeries BBiotechUnited States
17 participantsAdage Capital Partners L.P.ARCH Venture PartnersBlue Owl Healthcare OpportunitiesBoxer CapitalFairmountFarallon Capital ManagementFidelity Management & Research CompanyInc.InvusLogos CapitalMoore Strategic VenturesOrbiMedPoint72TCGXT. Rowe Price Investment ManagementVenrock Healthcare Capital PartnersWoodline Partners LP
Parabilis Medicines

Develops medicines targeting historically undruggable protein targets in cancer

$305MSeries FBiotechUnited States
23 participantsAlderline GroupARCH Venture PartnersCatalio Capital ManagementCormorant Asset ManagementFarallon Capital ManagementFidelity Management & Research CompanyForesite CapitalFrazier Life SciencesGeneral CatalystGV (Google Ventures)HBM HealthcareInvusJanus Henderson InvestorsMarshall WaceMilky Way InvestmentsNextech InvestRA Capital ManagementRock Springs CapitalSamsara BioCapitalSixty Degree CapitalSoleus CapitalT. Rowe Price AssociatesvenBio Partners